These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2285291)
1. In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases. Kitzis MD; Liassine N; Ferré B; Gutmann L; Acar JF; Goldstein F Antimicrob Agents Chemother; 1990 Sep; 34(9):1783-6. PubMed ID: 2285291 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. Rice LB; Yao JD; Klimm K; Eliopoulos GM; Moellering RC Antimicrob Agents Chemother; 1991 Jun; 35(6):1243-4. PubMed ID: 1929273 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases. Endimiani A; Choudhary Y; Bonomo RA Antimicrob Agents Chemother; 2009 Aug; 53(8):3599-601. PubMed ID: 19528274 [No Abstract] [Full Text] [Related]
4. Characterization of the extended-spectrum beta-lactamases and determination of the antibiotic susceptibilities of Klebsiella pneumoniae isolates in Hungary. Pragai Z; Koczian Z; Nagy E J Antimicrob Chemother; 1998 Sep; 42(3):401-3. PubMed ID: 9786486 [No Abstract] [Full Text] [Related]
5. [Comparative antibacterial activity of ceftibuten (SH 39 720) against 150 K. pneumoniae strains producing different beta-lactamases]. Thabaut A; Meyran M Pathol Biol (Paris); 1990 May; 38(5):347-51. PubMed ID: 2195446 [TBL] [Abstract][Full Text] [Related]
6. [Effect of broad spectrum beta-lactamases on in vitro sensitivity of clinical isolates of Klebsiella pneumoniae to oral cephalosporins]. Bedenić B; Singer S Lijec Vjesn; 2000; 122(1-2):8-13. PubMed ID: 10916350 [TBL] [Abstract][Full Text] [Related]
7. Interactions of ceftibuten with extended-spectrum beta-lactamases: a bacteriological and enzymatic analysis. Thabaut A; Meyran M; Sofer L; Morand A; Labia R Drugs Exp Clin Res; 1994; 20(2):49-54. PubMed ID: 7924896 [TBL] [Abstract][Full Text] [Related]
9. The frequency of extended-spectrum beta-lactamases in isolates of Klebsiella pneumoniae. Katsanis G; Jacoby G J Antimicrob Chemother; 1992 Mar; 29(3):345-6. PubMed ID: 1592702 [No Abstract] [Full Text] [Related]
10. Klebsiella pneumoniae strains carrying the chromosomal SHV-11 beta-lactamase gene produce the plasmid-mediated SHV-12 extended-spectrum beta-lactamase more frequently than those carrying the chromosomal SHV-1 beta-lactamase gene. Lee YH; Cho B; Bae IK; Chang CL; Jeong SH J Antimicrob Chemother; 2006 Jun; 57(6):1259-61. PubMed ID: 16595640 [No Abstract] [Full Text] [Related]
11. SHV-13, a novel extended-spectrum beta-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam. Yuan M; Hall LM; Savelkoul PH; Vandenbroucke-Grauls CM; Livermore DM Antimicrob Agents Chemother; 2000 Apr; 44(4):1081-4. PubMed ID: 10722518 [TBL] [Abstract][Full Text] [Related]
12. Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: effect of large inocula. Medeiros AA; Crellin J Pediatr Infect Dis J; 1997 Mar; 16(3 Suppl):S49-55. PubMed ID: 9076836 [TBL] [Abstract][Full Text] [Related]
13. Characterization of extended spectrum beta-lactamase-producing Klebsiella pneumoniae from Beijing, China. Shen D; Winokur P; Jones RN Int J Antimicrob Agents; 2001 Aug; 18(2):185-8. PubMed ID: 11516943 [TBL] [Abstract][Full Text] [Related]
14. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia. Palasubramaniam S; Muniandy S; Navaratnam P J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644 [TBL] [Abstract][Full Text] [Related]
15. Epidemic and endemic spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase in Dubrava University Hospital, Zagreb, Croatia. Bedenić B; Schmidt H; Herold S; Monaco M; Plecko V; Kalenić S; Katíc S; Skrlin-Subić J J Chemother; 2005 Aug; 17(4):367-75. PubMed ID: 16167514 [TBL] [Abstract][Full Text] [Related]
16. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase. Elliott E; Brink AJ; van Greune J; Els Z; Woodford N; Turton J; Warner M; Livermore DM Clin Infect Dis; 2006 Jun; 42(11):e95-8. PubMed ID: 16652304 [TBL] [Abstract][Full Text] [Related]
17. Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea. Jeong SH; Bae IK; Kwon SB; Lee JH; Jung HI; Song JS; Jeong BC; Kim SJ; Lee SH Lett Appl Microbiol; 2004; 39(1):41-7. PubMed ID: 15189286 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the in vitro activity of meropenem against strains of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in the city of Fortaleza, Ceará]. Menezes EA; do Nascimento KM; Soares KP; Amorim LN; Lima Neto JG; Cunha FA Rev Soc Bras Med Trop; 2007; 40(3):349-50. PubMed ID: 17653476 [TBL] [Abstract][Full Text] [Related]
19. Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection. MacKenzie FM; Miller CA; Gould IM Clin Microbiol Infect; 2002 Nov; 8(11):715-24. PubMed ID: 12445009 [TBL] [Abstract][Full Text] [Related]
20. Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Procop GW; Tuohy MJ; Wilson DA; Williams D; Hadziyannis E; Hall GS Am J Clin Pathol; 2003 Aug; 120(2):265-7. PubMed ID: 12931557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]